REQUEST A DEMO
Total
USD $0.00
Search more companies

Maxigen Biotech Inc. (和康生物科技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Maxigen Biotech Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Maxigen Biotech Inc. (和康生物科技股份有限公司) is based in Taiwan, China, with the head office in Taoyuan City. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on December 03, 1998. 127 (2023) employees currently work for Maxigen Biotech Inc. (和康生物科技股份有限公司). From the latest financial highlights, Maxigen Biotech Inc. (和康生物科技股份有限公司) reported a net sales revenue increase of 23.54% in Q3C2025. Its’ total assets recorded a growth of 11.39%. The net profit margin of Maxigen Biotech Inc. (和康生物科技股份有限公司) increased by 1.96% in 2025.

Headquarters
No.88, Keji 1St Rd., Guishan Dist
Taoyuan City; Taoyuan City;

Contact Details: Purchase the Maxigen Biotech Inc. (和康生物科技股份有限公司) report to view the information.

Website: http://www.mbi.com.tw

Basic Information
Total Employees:
Purchase the Maxigen Biotech Inc. (和康生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Maxigen Biotech Inc. (和康生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Maxigen Biotech Inc. (和康生物科技股份有限公司) report to view the information.
Incorporation Date:
December 03, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
27.51%
Purchase this report to view the information.
9.7%
Purchase this report to view the information.
5.31%
Purchase this report to view the information.
3.93%
Purchase this report to view the information.
2.72%
Subsidiaries
河康生物科技(上海)有限公司 (China)
100%
TCI Co.,Ltd
2.14%
Company Performance
Financial values in the chart are available after Maxigen Biotech Inc. (和康生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
23.54%
Total Operating Revenue
23.63%
Operating Profit
32.14%
EBITDA
29.47%
Net Profit/Loss for the Period
31.89%
Total Assets
11.39%
Total Equity
10.41%
Operating Profit Margin
1.83%
Net Profit Margin
1.96%
Return on Equity (ROE)
2%
Debt / Equity
94%
Quick Ratio
434.63%
Cash Ratio
0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?